SCHEMBL28057541

SCHEMBL28057541

O=C(O)Cc1cnc(CCOc2ccc(Cl)cc2)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.47
▸ PTGDR2 Q9Y5Y4 3/20 0.46
▸ MAPT P10636 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ PPARA Q07869 3/20 0.42
▸ PPARG P37231 2/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ BRS3 P32247 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PPARD Q03181 2/20 0.39
▸ KCNH2 Q12809 1/20 0.38
▸ ALPL P05186 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28057576 0.82 MMP13 (0.46) GPR84PTGDR2MAPTTDP1PPARA
SCHEMBL28262433 0.77 GPR84 (0.49) GPR84MAPTTDP1TAAR1MEN1
SCHEMBL28057539 0.76 GPR84 (0.42) GPR84PTGDR2MAPTTDP1PPARA
SCHEMBL1387583 0.71 ALDH1A1 (0.42) MAPTBRS3ALDH1A1NFKB1
SCHEMBL11596852 0.70 PLA2G4B (0.56) PTGDR2PPARGTAAR1MEN1KMT2A
SCHEMBL355627 0.69 L3MBTL1 (0.67) PPARAPPARGMCL1TAAR1MEN1
SCHEMBL8582394 0.68 L3MBTL1 (0.61) MCL1
SCHEMBL7345076 0.68 BRS3 (0.49) BRS3TAAR1
SCHEMBL120716 0.68 KMT2A (0.58) PPARAMEN1KMT2AALDH1A1LMNA
SCHEMBL28536384 0.66 PPARA (0.63) PPARAMEN1KMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105431416-A 4-alkynyl imidazole derivative and medicine comprising same as active ingredient KAKEN PHARMA CO LTD 2016-03-23 — — CN disclosed
Send feedback